Cargando…

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging

OBJECTIVE: Recent availability of amyloid and tau positron emission tomography (PET) has provided us with a unique opportunity to measure the association of systemic vascular health with brain health after accounting for the impact of Alzheimer disease (AD) pathologies. We wanted to quantify early c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vemuri, Prashanthi, Lesnick, Timothy G., Przybelski, Scott A., Graff‐Radford, Jonathan, Reid, Robert I., Lowe, Val J., Zuk, Samantha M., Senjem, Matthew L., Schwarz, Christopher G., Gunter, Jeffrey L., Kantarci, Kejal, Machulda, Mary M., Mielke, Michelle M., Petersen, Ronald C., Knopman, David S., Jack, Clifford R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6282853/ https://www.ncbi.nlm.nih.gov/pubmed/30264411 http://dx.doi.org/10.1002/ana.25346

Ejemplares similares

White matter abnormalities are key components of cerebrovascular disease impacting cognitive decline
por: Vemuri, Prashanthi, et al.
Publicado: (2021)

Imaging Biomarkers of Alzheimer Disease in Multiple Sclerosis
por: Zeydan, Burcu, et al.
Publicado: (2020)

Relationship Between Risk Factors and Brain Reserve in Late Middle Age: Implications for Cognitive Aging
por: Neth, Bryan J., et al.
Publicado: (2020)

Amyloid, Vascular, and Resilience Pathways Associated with Cognitive Aging
por: Vemuri, Prashanthi, et al.
Publicado: (2019)

Study of Symptomatic vs. Silent Brain Infarctions on MRI in Elderly Subjects
por: Raghavan, Sheelakumari, et al.
Publicado: (2021)

Vascular and amyloid pathologies are independent predictors of cognitive decline in normal elderly
por: Vemuri, Prashanthi, et al.
Publicado: (2015)

White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease
por: Tian, Jianqiao, et al.
Publicado: (2023)

Diffusion models reveal white matter microstructural changes with ageing, pathology and cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2021)

Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
por: Schwarz, Christopher G., et al.
Publicado: (2023)

Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET
por: Nedelska, Zuzana, et al.
Publicado: (2018)

Investigation of white matter PiB uptake as a marker of white matter integrity
por: Zeydan, Burcu, et al.
Publicado: (2019)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers
por: Cogswell, Petrice M., et al.
Publicado: (2023)

Coping with brain amyloid: genetic heterogeneity and cognitive resilience to Alzheimer’s pathophysiology
por: Ramanan, Vijay K., et al.
Publicado: (2021)

Effect of intellectual enrichment on AD biomarker trajectories: Longitudinal imaging study
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Longitudinal deterioration of white-matter integrity: heterogeneity in the ageing population
por: Poulakis, Konstantinos, et al.
Publicado: (2021)

Neuropathologic scales of cerebrovascular disease associated with diffusion changes on MRI
por: Nguyen, Aivi T., et al.
Publicado: (2022)

Face recognition from research brain PET: An unexpected PET problem
por: Schwarz, Christopher G., et al.
Publicado: (2022)

Non-Stationarity in the “Resting Brain’s” Modular Architecture
por: Jones, David T., et al.
Publicado: (2012)

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2022)

Cross–scanner harmonization methods for structural MRI may need further work: A comparison study
por: Gebre, Robel K., et al.
Publicado: (2023)

Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia
por: Nedelska, Zuzana, et al.
Publicado: (2019)

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
por: Jack, Clifford R, et al.
Publicado: (2019)

Improved DTI registration allows voxel-based analysis that outperforms Tract-Based Spatial Statistics
por: Schwarz, Christopher G., et al.
Publicado: (2014)

Relationships between β-amyloid and tau in an elderly population: An accelerated failure time model
por: Therneau, Terry M., et al.
Publicado: (2021)

(1)H-MRS metabolites and rate of β-amyloid accumulation on serial PET in clinically normal adults
por: Nedelska, Zuzana, et al.
Publicado: (2017)

Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk
por: Jack, Clifford R., et al.
Publicado: (2022)

β-Amyloid PET and neuropathology in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2020)

Associations of quantitative susceptibility mapping with Alzheimer’s disease clinical and imaging markers
por: Cogswell, Petrice M., et al.
Publicado: (2020)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation
por: Schwarz, Christopher G., et al.
Publicado: (2021)

Association of Cerebrovascular Imaging Biomarkers, Depression, and Anxiety, with Mild Cognitive Impairment
por: Vassilaki, Maria, et al.
Publicado: (2023)

Predicting future rates of tau accumulation on PET
por: Jack, Clifford R, et al.
Publicado: (2020)

Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer's disease and vascular pathology
por: Shir, Dror, et al.
Publicado: (2022)

β-Amyloid PET and (123)I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia
por: Chen, Qin, et al.
Publicado: (2021)

Causal structure discovery identifies risk factors and early brain markers related to evolution of white matter hyperintensities
por: Shen, Xinpeng, et al.
Publicado: (2022)

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
por: Jack, Clifford R., et al.
Publicado: (2015)

Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework
por: Jack, Clifford R., et al.
Publicado: (2019)

Imaging markers of cerebrovascular pathologies: Pathophysiology, clinical presentation, and risk factors
por: Raman, Mekala R., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_4oht6tvfokl7m7e6grh1umc1jt